A global care package for women: Gender-neutral human papillomavirus eradication. Read more about A global care package for women: Gender-neutral human papillomavirus eradication.
Determining the impact of Medicaid expansion on cancer burden. Read more about Determining the impact of Medicaid expansion on cancer burden.
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer. Read more about Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Obesity, race, and long-term prostate cancer outcomes. Read more about Obesity, race, and long-term prostate cancer outcomes.
The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples. Read more about The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples.
Breast cancer treatment: A phased approach to implementation. Read more about Breast cancer treatment: A phased approach to implementation.
New mammography screening performance metrics based on the entire screening episode. Read more about New mammography screening performance metrics based on the entire screening episode.
Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer. Read more about Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer.
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study. Read more about Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer. Read more about Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer.
